Milestone Scientific (MLSS) Gains from Sales and Divestitures (2022 - 2025)
Milestone Scientific (MLSS) has disclosed Gains from Sales and Divestitures for 4 consecutive years, with $1.7 million as the latest value for Q4 2025.
- Quarterly Gains from Sales and Divestitures rose 141.02% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, up 141.02% year-over-year, with the annual reading at $1.7 million for FY2025, 141.02% up from the prior year.
- Gains from Sales and Divestitures hit $1.7 million in Q4 2025 for Milestone Scientific, up from $337081.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $1.7 million in Q4 2025 to a low of $173443.0 in Q1 2024.
- Historically, Gains from Sales and Divestitures has averaged $473299.7 across 4 years, with a median of $337081.0 in 2025.
- Biggest five-year swings in Gains from Sales and Divestitures: tumbled 39.29% in 2024 and later soared 141.02% in 2025.
- Year by year, Gains from Sales and Divestitures stood at $449695.0 in 2022, then skyrocketed by 54.47% to $694658.0 in 2023, then decreased by 0.22% to $693106.0 in 2024, then skyrocketed by 141.02% to $1.7 million in 2025.
- Business Quant data shows Gains from Sales and Divestitures for MLSS at $1.7 million in Q4 2025, $337081.0 in Q3 2025, and $337081.0 in Q2 2025.